Waissengrin, B., Agbarya, A., Safadi, E., Padova, H., & Wolf, I. (2021). Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors. Lancet Oncol.
Chicago Style CitationWaissengrin, Barliz, Abed Agbarya, Esraa Safadi, Hagit Padova, and Ido Wolf. "Short-term Safety of the BNT162b2 MRNA COVID-19 Vaccine in Patients With Cancer Treated With Immune Checkpoint Inhibitors." Lancet Oncol 2021.
MLA CitationWaissengrin, Barliz, et al. "Short-term Safety of the BNT162b2 MRNA COVID-19 Vaccine in Patients With Cancer Treated With Immune Checkpoint Inhibitors." Lancet Oncol 2021.
Warning: These citations may not always be 100% accurate.